Qualification 

• Primary Medical Degree (M.B.B.S.): 2001 / JJM Medical College, Davangere, Karnataka, India. (Convocation Held & Degree Conferred: 02/6/2003).
• Post-Graduate (M.D. In General Medicine): 2006 / Vijayanagara Institute Of Medical Sciences, Bellary, Karnataka, India. (Convocation Held & Degree Conferred On 24/3/2007).
• Super-Specialization: [D.M. {Doctor Of Medicine} In Medical Oncology]: 2012 / The Gujarat Cancer And Research Institute, Ahmedabad, Gujarat, India. (Convocation Held & Degree Conferred On 05/03/2013).
• ESMO Examination Certificate: Passed The ESMO Examination Held In Mumbai, India On 29th September 2012 And Was Accredited With 50 ESMO-MORA Points.

Past Positions

• 08th January 2018 Till Date: Working As Consultant Medical Oncologist At Care Hospitals, Hyderabad 01st August 2014 Till 7th January 2018: Worked As Consultant Medical Oncologist At American Oncology Institute, Serilingampally, Hyderabad. 18th July 2013 Till July 2014:
• Worked As Consultant Medical Oncologist At Basavatarakam Indo-American Cancer Hospital And Research Institute. 17th October 2012 Till 15th July 2013: Worked As Consultant Medical Oncologist At Viswabharathi Cancer Hospital
• A Comprehensive Cancer Care Centre At Kurnool. 29th September 2009 To 28TH September 2012: D.M. Tenure Of Three Years (1st Year, 2nd Year And 3rd Year D.M. Residency Curriculum) Under
• Dr. Apurva A. Patel As My Principal Teacher And Guide At The Gujarat Cancer Institute And Research Centre, B.J. Medical College, Ahmedabad, Gujarat, India August 2007 To September 2009: Worked As Assistant Professor Of Medicine At V.I.M.S. Bellary, Karnataka, India
• January 2007 To August 2007: Worked As Lecturer In Medicine At Sri Devaraj Urs Academy Of Higher Education & Research, Tamka, Kolar, Karnataka, India October 2003 Till September 2006:
• Post-Graduation, A M.D. Tenure Of Three Years In General Medicine (1st Year, 2nd Year And 3rd Year M.D. Residency Curriculum)) Under Dr. Jayaprakash. B, As My Principal Teacher And Guide From V.I.M.S. Bellary, Karnataka, India.

 Skills / Expertise 

Management Of Various Solid And Haematological Malignancies In Both Adult And Paediatric Patients. Well-Versed With Various Frontline Protocols Like (A) BFM 90, BFM 95 And MCP 841 Protocols For Paediatric A.L.L. BFM 93 For Paediatric A.M.L. And “7+3”/DAT Protocols For Adult A.M.L. ABVD, COPP, LMB 89, BFM 86, Hyper CVAD, CODOX-M/IVAC, And Murphy‟S Protocols For Paediatric Lymphomas FLAG, FLAG-Ida, DHAP, ASHAP, ESHAP, R-ICE And GVD Protocols For Relapsed Leukemias And Lymphomas High Dose Ifosfamide / Cyclophosphamide And High Dose Methotrexate Based Regimens For Sarcomas (Soft Tissue And Bone). BEAM, BuCy, HD Melphalan For Stem Cell Transplants Conventional Protocols Like FAC, CMF, AT, AC --›T For Breast Cancer; Platinum-Based Regimens For Lung, Testicular And Ovarian Cancers; P+F, TPF, DCF For Head And Neck Cancers; LV5FU, FOLFOX, FOLFIRI, CAPOX, CAPIRI Etc. Experience With Newer Molecules Like Rituximab, Cetuximab, Herceptin, Bevacizumab, Nimotuzumab, Velcade, Gefitinib, Everolimus Etc. Management Of Febrile Neutropenia (J) Maintenance Of Chemoports, Central Catheters, PICCs, Etc.

 Publications 

Authored “Neutropenic Enterocolitis In A Child With Acute Myeloid Leukemia Successfully Treated With Early Surgical Intervention: A Case Report”. Published Online On 15th July 2012 Of Indian Society Of Haematology & Transfusion Medicine 2012. Authored “Experience With Hickman Catheter And Implantable Ports At GCR” Volume 14, Number 1 April 2012. Gujarat Cancer Society Research Journal : 28-29. Presented A Poster Titled “Experience With Hickman Catheter And Implantable Ports At GCR” In Biennial Joint Conference Of ISMPO (Indian Society Of Medical & Paediatric Oncology) And ISO (Indian Society Of Oncology) Held At Bhubaneshwar, 2011. Authored “Experience With Hickman Catheter And Implantable Ports At GCR” Volume 14 Number 1 April 2012. Gujarat Cancer Society Research Journal : 28-29.

 Research & Presentations 

Efficacy And Safety Of Paclitaxel Nano-Dispersion Concentrate For Injection (PICN) In Subjects With Metastatic Breast Cancer: A Randomized, Open Label, Active Controlled, Comparative, Parallel Group, And Multi-Centric Study. A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Clinical Trial To Study The Safety, Tolerability, Efficacy, And Immunogenecity Of V212 In Recipients Of Autologous Hematopoietic Cell Transplants (HCTs).

  Memberships 

Member Of ESMO (European Society Of Medical Oncology) Since 2012 Member Of ICON (Indian Co-Operative Oncology Network) Member Of ISHBT (Indian Society Of Hematology And Blood Transfusion) Member Of MOF (Medical Oncology Forum)